Lilly, Novo Slide as Trump Touts ‘Much Lower’ Ozempic Price
NegativeFinancial Markets

President Donald Trump announced that the price of the diabetes medication Ozempic is expected to drop significantly, potentially to $150 a month. This news has negatively impacted the stock prices of major pharmaceutical companies Novo Nordisk and Eli Lilly. The announcement highlights ongoing discussions about drug pricing in the U.S. and could lead to increased competition in the diabetes treatment market, affecting both patients and investors.
— Curated by the World Pulse Now AI Editorial System